Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|January 25, 2026
Revisiting Prophylactic Corticosteroids to Mitigate Severe Immune-Related Adverse Events in Hepatocellular CarcinomaYing-Chun Shen, David J Pinato, Tsung-Hao Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2010
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3Kuen-Feng Chen, Wei-Tien Tai, Tsung-Hao Liu, et al.
Liver Cancer|April 26, 2019
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib TreatmentLi-Chun Lu, Yi-Hsuan Lee, Chun-Jung Chang, et al.
British Journal of Cancer|March 25, 2025
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trialYu-Yun Shao, Ching-Tso Chen, Chien-Huai Chuang, et al.
Cancers|October 23, 2021
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving ImmunotherapyYing-Chun Shen, Ching-Ping Yeh, Yung-Ming Jeng, et al.
European Radiology|July 21, 2022
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
Journal of Hepatocellular Carcinoma|June 10, 2024
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular CarcinomaBang-Bin Chen, Po-Chin Liang, Tiffany Ting-Fang Shih, et al.
Liver Cancer|December 5, 2019
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular CarcinomaLi-Chun Lu, Chiun Hsu, Yu-Yun Shao, et al.
Journal of Hepatocellular Carcinoma|August 2, 2021
An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular CarcinomaYing-Chun Shen, Pei-Chang Lee, Yu-Lun Kuo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 17, 2025
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian StudyYuta Maruki, Yasushi Yatabe, Chiharu Mizoguchi, et al.
Pageof 3